(Q44103718)

English

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort

scientific article published on 14 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Signe Borgquist

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Karin Elebro

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Salma Butt

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Mozhgan Dorkhan

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Helena Jernström

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

14 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Cancer Causes & Control

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

945-957

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s10552-014-0394-2

0 references

Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor expression and breast cancer survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Expression of androgen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Tamoxifen-stimulated growth of breast cancer due to p21 loss

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor in triple negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Role of the androgen receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Testosterone effects on the breast: implications for testosterone therapy for women.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Breast tumours following combined hormone replacement therapy express favourable prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Targeting androgen receptor in estrogen receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

The protective role of pregnancy in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Reproductive risk factors for breast cancer by receptor status, histology, laterality and location

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Parity and age at first childbirth in relation to the risk of different breast cancer subgroups

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgens and the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Waist and hip circumferences and waist-hip ratio in 19 populations of the WHO MONICA Project

1 reference

https://api.crossref.org/works/10.1007%2FS10552-014-0394-2

21 January 2018

Identifiers

10.1007/S10552-014-0394-2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44103718&oldid=2106617750"